Buy Like Buffett
Watchlist

Flagship explainer

How BIO-RAD LABORATORIES, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$2.6B · 100%Cost of revenue$1.2B · 48%Gross profit$1.3B · 52%Operating income$47.2M · 2%Income before tax$996M · 39%Income tax$236M · 9%Net income$760M · 29%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$2.6B100%
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
Cost of revenue$1.2B48%
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
$1.3B52%
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
$47.2M2%
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
Income before tax$996M39%
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
Income tax$236M9%
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
$760M29%
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0000012208-26-000010 · filed Feb 13, 2026
· event Dec 31, 2025 · retrieved Oct 17, 2026 · annual-row source set
Embed this chart

View the full BIO-RAD LABORATORIES, INC. analysis at Buy Like Buffett